Tandem Diabetes Care (TNDM) Debt Ratio (2013 - 2025)

Tandem Diabetes Care's (TNDM) quarterly Debt Ratio came in at 0.04 in Q1 2025, up 5.11% quarter-over-quarter from 0.04 in Q4 2024.

Analysis

Tandem Diabetes Care (TNDM) Debt Ratio (2013 - 2025) Analysis & Trends

Tandem Diabetes Care (TNDM) has reported Debt Ratio for 8 consecutive years, with 0.04 the latest figure, recorded in Q1 2025.

For the quarter ending Q1 2025, Debt Ratio changed N/A year-over-year to 0.04; the trailing twelve-month figure through Mar 2025 stood at 0.04 (changed N/A YoY), and the FY2024 full-year result was 0.04, changed N/A from the prior year.
Debt Ratio climbed to 0.04 in Q1 2025 per TNDM's latest filing, from 0.04 in the prior quarter.
Across five years, Debt Ratio topped out at 0.04 in Q1 2025 and bottomed at 0.04 in Q4 2024.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	179.79 Bn	174.18 Bn	7.27 Bn	0.30
2	Intuitive Surgical	127.69 Bn	122.47 Bn	1.96 Bn	-
3	Medtronic	117.23 Bn	108.41 Bn	6.34 Bn	0.30
4	Stryker	103.55 Bn	100.07 Bn	4.50 Bn	0.31
5	Boston Scientific	63.24 Bn	62.70 Bn	3.85 Bn	0.28
6	Edwards Lifesciences	49.97 Bn	45.72 Bn	1.35 Bn	0.04
7	Alcon	32.83 Bn	31.37 Bn	1.68 Bn	0.13
8	Dexcom	32.30 Bn	30.35 Bn	830.00 Mn	-
9	Steris	20.73 Bn	20.25 Bn	684.20 Mn	0.20
10	Tandem Diabetes Care	1.26 Bn	804.14 Mn	144.78 Mn	-

Historic Data

Download Data